Φορτώνει......
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils
Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Biol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370375/ https://ncbi.nlm.nih.gov/pubmed/30426827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529113 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|